| |
Organized
by the Office of Science & Technology of the Embassy of
France in the United States (Boston section), the French
American Innovation Day (FAID) is designed to emphasize a
specific topic that is significant to science, therapeutics
and innovation. With the support of the Massachusetts Life
Sciences Center (MLSC), the 2010 FAID seminar will address the
latest research in Alzheimer's disease (AD) in France and the
United States. |
 |
WHY ADDRESS AD IN A BILATERAL JOIN
EVENT?
•
Alzheimer’s disease (AD) is a devastating
neurodegenerative disorder that currently affects millions of
French and Americans.
• A new report from the
Alzheimer's Association shows that the number of Americans age
65 and older who have this condition will increase from
the 5.1 million today to 13.5 million by
mid-century.
• Total costs
of care for individuals with Alzheimer's disease by all payers
will soar from $172 billion in 2010 to more
than $1 trillion in 2050, with Medicare costs
increasing more than 600 percent, from $88 billion
today to $627 billion in 2050.
READ MORE |


|
 |
| Attendance is free of charge but
registration is required |
| |
SPONSORSHIP OPPORTUNITIES |
| Discover the benefits of becoming
a sponsor for this unique seminar. |
 |
|
|